Céline Mascaux
About
In The Last Decade
Céline Mascaux
129 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 128
- Pulmonary and Respiratory Medicine 2.8k
- Oncology 2.5k
- Molecular Biology 1.7k
- Cancer Research 998
- Radiology, Nuclear Medicine and Imaging 687
Countries citing papers authored by Céline Mascaux
This map shows the geographic impact of Céline Mascaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Mascaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Mascaux more than expected).
Fields of papers citing papers by Céline Mascaux
This network shows the impact of papers produced by Céline Mascaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Mascaux. The network helps show where Céline Mascaux may publish in the future.
Co-authorship network of co-authors of Céline Mascaux
This figure shows the co-authorship network connecting the top 25 collaborators of Céline Mascaux. A scholar is included among the top collaborators of Céline Mascaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Mascaux. Céline Mascaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 34 | |
| 6 | 31 | |
| 7 | 0 | |
| 8 | 67 | |
| 9 | 12 | |
| 10 | 29 | |
| 11 | El valor de captacion estandarizado (SUVmax) del tumor primario medido con tomografia de emission de postrones con fluorodesoxiglucosa (FDG-PET) tiene valor pronostico para la supervivencia en el cancer de pulmon no microcitico (CPNMC): Una revision sistematica y metaanalisis (MA) del European Lung Cancer Working Party para el IASLC Lung Cancer Staging Project | 1 |
| 12 | 1 | |
| 13 | 8 | |
| 14 | Prognostic role of thyroid transcription factor (TTF-1) in lung cancer: a meta-analysis of the published studies | 0 |
| 15 | 111 | |
| 16 | VEGF et survie des patients atteints d'un cancer pulmonaire. Revue systématique avec méta-analyse. | 53 |
| 17 | Citation factors are not reflecting the methodological quality of lung cancer randomised trials. | 3 |
| 18 | Haematological colony-stimulating factor (CSF) in the treatment of small-cell lung cancer (SCLC): a systematic review of the literature with meta-analysis. | 0 |
| 19 | [The role of chemotherapy in the treatment of non-metastatic, non-small cell bronchial cancers]. | 4 |
| 20 | Phase II and III studies with new drugs for non small cell lung carcinoma: a systematic review of the literature with a methodology quality assessment | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.